Cargando…
MRP1 but Not MDR1 Is Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
A major problem in the treatment of breast cancer is the development of resistance to chemotherapeutic agents. Although the role of multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) in inducing drug resistance in many cancers has been widely investigated the clinical...
Autores principales: | Taheri, Mohsen, Mahjoubi, Frouzandeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809982/ https://www.ncbi.nlm.nih.gov/pubmed/23481629 http://dx.doi.org/10.3233/DMA-130985 |
Ejemplares similares
-
Expression of LRP Gene in Breast Cancer Patients Correlated with MRP1 as Two Independent Predictive Biomarkers in Breast Cancer
por: Taheri, Mohsen, et al.
Publicado: (2018) -
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023) -
MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients
por: Micsik, Tamás, et al.
Publicado: (2015) -
MDR1-EXPRESSING CD4(+) T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE
por: Di Roio, Anthony, et al.
Publicado: (2023) -
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice
por: van der Deen, Margaretha, et al.
Publicado: (2007)